Vogt-Koyanagi-Harada disease-like posterior uveitis in the course of nivolumab (anti-PD-1 antibody), interposed by vemurafenib (BRAF inhibitor), for metastatic cutaneous malignant melanoma
- PMID: 28469878
- PMCID: PMC5412830
- DOI: 10.1002/ccr3.911
Vogt-Koyanagi-Harada disease-like posterior uveitis in the course of nivolumab (anti-PD-1 antibody), interposed by vemurafenib (BRAF inhibitor), for metastatic cutaneous malignant melanoma
Abstract
A patient with metastatic cutaneous malignant melanoma developed Vogt-Koyanagi-Harada disease-like posterior uveitis after two nivolumab (anti-PD-1 antibody) injections. Vogt-Koyanagi-Harada disease, with the background of autoimmunity against choroidal melanocytes, suggests nivolumab be working by disintegrating inhibition circuit of T cells against a common epitope shared between melanoma cells and normal melanocytes.
Keywords: BRAF inhibitor; PD‐1; Vogt‐Koyanagi‐Harada disease; nivolumab; uveitis; vemurafenib.
Figures
References
-
- Moorthy, R. S. , Inomata H., and Rao N. A.. 1995. Vogt‐Koyanagi‐Harada syndrome. Surv. Ophthalmol. 39:265–292. - PubMed
-
- Sakata, V. M. , da Silva F. T., Hirata C. E., de Carvalho J. F., and Yamamoto J. H.. 2014. Diagnosis and classification of Vogt‐Koyanagi‐Harada disease. Autoimmun. Rev. 13:550–555. - PubMed
-
- Ishihara, K. , Hangai M., Kita M., and Yoshimura N.. 2009. Acute Vogt‐Koyanagi‐Harada disease in enhanced spectral‐domain optical coherence tomography. Ophthalmology 116:1799–1807. - PubMed
-
- Gupta, V. , Gupta A., Gupta P., and Sharma A.. 2009. Spectral‐domain cirrus optical coherence tomography of choroidal striations seen in the acute stage of Vogt‐Koyanagi‐Harada disease. Am. J. Ophthalmol. 147:148–153. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
